19/02/2026
A proud moment to represent India’s healthtech ecosystem at the Indo-French CEO Dialogue in New Delhi, convened by the Governments of India and France during Emmanuel Macron’s official visit alongside the India AI Impact Summit.
At that distinguished gathering, Redcliffe Labs stood as the one and only Indian healthtech company, represented by Founder and Chairman Dheeraj Jain. It was not just a presence in the room; it reflected the growing strength of India’s voice in global healthcare. We were honoured to be part of an inspiring Indian delegation alongside leaders such as Sukaran Singh of Tata Advanced Systems and S K Poddar of Adventz Group, who showcased powerful stories of Indian innovation to the world.
In discussions across the forum, we shared how India is shaping a new healthcare model. One measured by clinical outcomes, guided by AI-driven intelligence, and designed to deliver care affordably at a population scale. India is no longer exporting services alone. India is building a healthcare architecture that can travel across borders.
From accessible diagnostics that deliver strong clinical outcomes at scale to AI-powered innovations such as face-scan-based risk detection that can flag metabolic and cardiovascular risks within minutes, the vision is simple. Detect earlier. Act sooner. Reduce long-term disease burden. Make prevention smarter and sustainable.
What stood out in these conversations was a new confidence. India is not seeking validation. India is ready to collaborate, co-create, and invest globally. We are no longer known only for cost efficiency. We are recognised for technology leadership, clinical intelligence, and scalable healthcare innovation.
This milestone belongs to a larger Indian healthcare ecosystem that is quietly transforming how the world thinks about access, prevention, and trust in care.
Grateful for the opportunity. Proud of the journey. Energised for what comes next.
